First Trust Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $74.8M | Buy |
1,111,188
+152,556
| +16% | +$10.2M | 0.04% | 466 |
|
|
2026
Q1 | $60.2M | Sell |
958,632
-90,454
| -9% | -$6.3M | 0.04% | 505 |
|
|
2025
Q4 | $69.6M | Buy |
1,049,086
+34,627
| +3% | +$2.24M | 0.05% | 435 |
|
|
2025
Q3 | $68.3M | Buy |
1,014,459
+163,818
| +19% | +$13M | 0.05% | 449 |
|
|
2025
Q2 | $74.3M | Buy |
850,641
+204,145
| +32% | +$16M | 0.06% | 401 |
|
|
2025
Q1 | $44.1M | Buy |
646,496
+88,597
| +16% | +$7.23M | 0.04% | 591 |
|
|
2024
Q4 | $43.4M | Buy |
557,899
+106,754
| +24% | +$7.9M | 0.04% | 588 |
|
|
2024
Q3 | $30.2M | Sell |
451,145
-9,882
| -2% | -$811K | 0.03% | 655 |
|
|
2024
Q2 | $52.3M | Buy |
461,027
+96,382
| +26% | +$12.2M | 0.05% | 444 |
|
|
2024
Q1 | $50.6M | Buy |
364,645
+112,724
| +45% | +$14.2M | 0.05% | 462 |
|
|
2023
Q4 | $31.3M | Sell |
251,921
-274,863
| -52% | -$28.1M | 0.03% | 574 |
|
|
2023
Q3 | $49.1M | Buy |
526,784
+171,927
| +48% | +$19.4M | 0.06% | 424 |
|
|
2023
Q2 | $45.6M | Sell |
354,857
-131,581
| -27% | -$15.9M | 0.05% | 467 |
|
|
2023
Q1 | $56.5M | Buy |
486,438
+334,657
| +220% | +$37.5M | 0.07% | 417 |
|
|
2022
Q4 | $17.2M | Sell |
151,781
-28,051
| -16% | -$3.08M | 0.02% | 780 |
|
|
2022
Q3 | $14.5M | Sell |
179,832
-204,502
| -53% | -$17.3M | 0.02% | 824 |
|
|
2022
Q2 | $28.6M | Buy |
384,334
+81,086
| +27% | +$7.4M | 0.04% | 585 |
|
|
2022
Q1 | $38.8M | Sell |
303,248
-161,580
| -35% | -$17.7M | 0.04% | 559 |
|
|
2021
Q4 | $62.4M | Buy |
464,828
+196,952
| +74% | +$28.3M | 0.06% | 442 |
|
|
2021
Q3 | $36.6M | Buy |
267,876
+111,352
| +71% | +$14M | 0.04% | 547 |
|
|
2021
Q2 | $16.6M | Sell |
156,524
-43,616
| -22% | -$4.19M | 0.02% | 847 |
|
|
2021
Q1 | $18M | Sell |
200,140
-189,040
| -49% | -$17.7M | 0.02% | 747 |
|
|
2020
Q4 | $36M | Sell |
389,180
-106,272
| -21% | -$9.49M | 0.05% | 482 |
|
|
2020
Q3 | $51.1M | Sell |
495,452
-150,504
| -23% | -$15.7M | 0.08% | 361 |
|
|
2020
Q2 | $65.5M | Sell |
645,956
-336,048
| -34% | -$30.1M | 0.11% | 221 |
|
|
2020
Q1 | $66.1M | Buy |
982,004
+298,916
| +44% | +$18.6M | 0.15% | 179 |
|
|
2019
Q4 | $37.4M | Sell |
683,088
-433,396
| -39% | -$20.6M | 0.06% | 449 |
|
|
2019
Q3 | $41.7M | Buy |
1,116,484
+872,752
| +358% | +$33.9M | 0.08% | 375 |
|
|
2019
Q2 | $9.13M | Sell |
243,732
-1,383,184
| -85% | -$43.5M | 0.02% | 811 |
|
|
2019
Q1 | $48.4M | Sell |
1,626,916
-69,380
| -4% | -$2.44M | 0.1% | 267 |
|
|
2018
Q4 | $50.8M | Buy |
1,696,296
+563,768
| +50% | +$17.9M | 0.12% | 207 |
|
|
2018
Q3 | $40.5M | Buy |
1,132,528
+253,724
| +29% | +$7.87M | 0.08% | 305 |
|
|
2018
Q2 | $20.9M | Buy |
878,804
+511,660
| +139% | +$10.8M | 0.04% | 561 |
|
|
2018
Q1 | $6.81M | Buy |
+367,144
| New | +$5.43M | 0.02% | 904 |
|
|
2017
Q4 | – | Sell |
-38,068
| Closed | -$466K | – | 2406 |
|
|
2017
Q3 | $466K | Sell |
38,068
-642,948
| -94% | -$11.4M | ﹤0.01% | 2108 |
|
|
2017
Q2 | $12.5M | Buy |
+681,016
| New | +$12.6M | 0.03% | 666 |
|
|
2017
Q1 | – | Sell |
-331,044
| Closed | -$4.94M | – | 2402 |
|
|
2016
Q4 | $4.94M | Sell |
331,044
-242,676
| -42% | -$4.3M | 0.01% | 1012 |
|
|
2016
Q3 | $12.6M | Buy |
573,720
+288,408
| +101% | +$6.42M | 0.04% | 638 |
|
|
2016
Q2 | $5.66M | Sell |
285,312
-318,432
| -53% | -$5.42M | 0.02% | 890 |
|
|
2016
Q1 | $10.3M | Sell |
603,744
-2,840,764
| -82% | -$47.5M | 0.03% | 648 |
|
|
2015
Q4 | $70.5M | Sell |
3,444,508
-1,195,740
| -26% | -$24.9M | 0.18% | 124 |
|
|
2015
Q3 | $99.6M | Buy |
+4,640,248
| New | +$104M | 0.29% | 71 |
|
Other funds holding DXCM
First Trust Advisors's DXCM Position: Q2 2026 in Review
First Trust Advisors increased its DexCom (DXCM) stake by 16% in Q2 2026, buying an estimated $10.2M and bringing the position to 1,111,188 shares worth $74.8M. The position accounts for 0.04% of the portfolio, ranked #466.
First Trust Advisors first reported a position in DXCM in Q3 2015 and has held it in 42 quarters since. The position peaked at $99.6M in Q3 2015. 966 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- First Trust Advisors held 1,111,188 shares of DexCom worth $74.8M as of Q2 2026.
- First Trust Advisors bought 152,556 DexCom shares in Q2 2026, an estimated $10.2M.
- DexCom made up 0.04% of First Trust Advisors's portfolio in Q2 2026, its #466 holding.
- First Trust Advisors first reported a position in DexCom in Q3 2015 and has held it in 42 quarters since.
- First Trust Advisors's DexCom position peaked at $99.6M in Q3 2015.
- 966 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.